Design, synthesis and bioevaluation of novel combretastatin A-4 based derivatives as potent tubulin/HDAC6 dual-target inhibitors for cancer therapy
2025, European Journal of Medicinal Chemistry 303:118456
- DOI:
http://dx.doi.org/https://doi.org/10.1016/j.ejmech.2025.118456
